Innovotech Inc.

Website Links

Description

Innovotech is a publicly listed company which develops products which address biofilm problems in a range of industry segments. The commercial opportunity in the biofilm sector is large. Awareness by researchers, practitioners, and client groups of the effects of biofilms in health care, agriculture and other industries is growing rapidly. The fact that no antibiotics, disinfectants, or diagnostics have been approved to address biofilm problems is a strong statement of the magnitude of opportunity this market provides to Innovotech. The company's lead product platform, bioFILM Antimicrobial Sensitivity Systems, has produced its first product, bioFILM PA™, which has Health Canada approval for use in the testing of Pseudomonas aeruginosa biofilms. This platform will produce several additional kits addressing market needs for improved sensitivity testing in biofilm related diseases. The company estimates that there exists a market potential of up to $ 200 M for such testing kits. The company's second product platform addresses biofilm diseases of agricultural crops for which treatments are either non-existent or inadequate. The company's lead product possesses a broad activity spectrum addressing both bacterial and fungal biofilms at competitive cost and low environmental impact. Innovotech expects market introduction of this product in 2010. In addition to its product development program, Innovotech also generates income through contract research services. These services play an important role in raising the awareness of biofilm problems in a variety of industries, and also provide the company with a close tie to the market and its most pressing needs. Innovotech is trading on the TSX-Venture Exchange under the symbol " IOT ". The company currently has a total of $22 M shares issued and outstanding.

Products & services

Similar companies nearby